» Authors » Michal Nowicki

Michal Nowicki

Explore the profile of Michal Nowicki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 342
Citations 2797
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Usinskis V, Nowicki M, Dzedzickis A, Bucinskas V
Sensors (Basel) . 2025 Feb; 25(4). PMID: 40006477
Navigation systems are developing rapidly; nevertheless, tasks are becoming more complex, significantly increasing the number of challenges for robotic systems. Navigation can be separated into global and local navigation. While...
2.
Jankowski M, Stefanska K, Suchodolski M, Dompe C, Wasiatycz G, Kempisty B, et al.
Front Genet . 2025 Jan; 15():1515778. PMID: 39834550
Introduction: Stem cells derived from adipose tissue are gaining popularity in the field of regenerative medicine due to their adaptability and clinical potential. Their rapid growth, ability to differentiate, and...
3.
Masajtis-Zagajewska A, Kurek R, Modrzynska K, Coker T, Nowicki M
J Clin Med . 2025 Jan; 14(1. PMID: 39797137
Chronic kidney disease (CKD) is associated with increased annual costs, with the highest costs attributable to renal replacement therapy (RRT). These costs will rise as prevalence increases. Therefore, forecasting the...
4.
Swierczewska M, Nowacka M, Stasiak P, Izycki D, Sterzynska K, Plociennik A, et al.
Biomed Pharmacother . 2025 Jan; 183:117804. PMID: 39787968
This study explores the mechanisms underlying chemotherapy resistance in ovarian cancer (OC) using doxorubicin (DOX) and topotecan (TOP)-resistant cell lines derived from the drug-sensitive A2780 ovarian cancer cell line. Both...
5.
Kot G, Wrobel A, Kuna K, Makowka A, Nowicki M
Medicina (Kaunas) . 2025 Jan; 60(12. PMID: 39768954
: This study aimed to evaluate the association between QoL, self-assessed physical activity, and the presence and severity of muscle spasms in chronic hemodialysis patients. Patients undergoing regular in-center hemodialysis...
6.
Podolec P, Mitkowski P, Slowik A, Gala-Bladzinska A, Gancarczyk U, Gil R, et al.
Kardiol Pol . 2025 Jan; 83(2):231-253. PMID: 39743907
Fabry disease (FD) belongs to the group of lysosomal storage diseases (LSD), characterized by insufficient enzyme activity responsible for the intra-lysosomal breakdown of various substrates. The result is an uncontrolled...
7.
Karolczak J, Przybylowska A, Szewczyk K, Taisner W, Heumann J, Stowell M, et al.
Bioinformatics . 2024 Dec; 41(1). PMID: 39700427
Motivation: Accurately identifying ligands plays a crucial role in the process of structure-guided drug design. Based on density maps from X-ray diffraction or cryogenic-sample electron microscopy (cryoEM), scientists verify whether...
8.
De Nicola L, Correa-Rotter R, Navarro-Gonzalez J, Power A, Nowicki M, Wittmann I, et al.
Kidney Int Rep . 2024 Dec; 9(12):3464-3476. PMID: 39698359
Introduction: Urinary albumin-to-creatinine ratio (uACR) is an independent predictor of chronic kidney disease (CKD) progression. However there is limited evidence on the burden of CKD according to uACR categories at...
9.
Roman M, Nowicki M
Int J Mol Sci . 2024 Nov; 25(22). PMID: 39596249
Minimal Change Disease (MCD) is a predominant cause of idiopathic nephrotic syndrome in the pediatric population, yet presents significant clinical challenges due to its frequent relapses and steroid resistance. Despite...
10.
Szukalska M, Grzeskowiak B, Bigaj-Jozefowska M, Witkowska M, Cicha E, Sujka-Kordowska P, et al.
Int J Nanomedicine . 2024 Nov; 19:12053-12078. PMID: 39583321
Purpose: Polydopamine nanoparticles (PDA NPs) have great potential in medicine. Their applications being widely investigated in cancer therapy, imaging, chemotherapy, photodynamic therapy (PDT), photothermal therapy (PTT), and tissue repair. The...